| AKT | Protein kinase B |
| ALP | Alkaline phosphatase |
| BALP | Bone-specific alkaline phosphatase |
| CaSR | Calcium-sensing receptor |
| CKD | Chronic kidney disease |
| CKD-MBD | Chronic kidney disease–mineral and bone disorder |
| CTX | C-terminal telopeptide of type I collagen |
| EGFR | Epidermal growth factor receptor |
| FGF23 | Fibroblast growth factor 23 |
| HBS | Hungry bone syndrome |
| ioPTH | Intraoperative parathyroid hormone |
| MAPK | Mitogen-activated protein kinase |
| mTOR | Mammalian target of rapamycin |
| NF-κB | Nuclear factor kappa B |
| OPG | Osteoprotegerin |
| P1NP | Procollagen type I N-terminal propeptide |
| PTH | Parathyroid hormone |
| PTX | Parathyroidectomy |
| RANKL | Receptor activator of nuclear factor κB ligand |
| SHPT | Secondary hyperparathyroidism |
| TGF-α | Transforming growth factor-α |
| TPV | Total parathyroid volume |
| TRACP-5b | Tartrate-resistant acid phosphatase-5b |
| TPTX + AT | Total parathyroidectomy with autotransplantation |
| VDRA | Vitamin D receptor activator |
| VDR | Vitamin D receptor |